{"id":63122,"date":"2026-05-18T13:03:09","date_gmt":"2026-05-18T11:03:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/"},"modified":"2026-05-18T13:03:09","modified_gmt":"2026-05-18T11:03:09","slug":"target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/","title":{"rendered":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science"},"content":{"rendered":"
\n

\nNew identities advance a modern approach to evidence generation<\/i><\/p>\n

DURHAM, N.C.–(BUSINESS WIRE)–Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health<\/a> and Headwater Science<\/a>. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges.<\/p>\n

<\/a>
<\/a><\/p>\n

\nPedestal Health (formerly Target RWE) is a full-service evidence generation partner for life sciences organizations. The company delivers scientifically rigorous, regulatory-ready longitudinal datasets that serve a variety of evidence generation needs, from traditional real-world evidence to externally controlled trials to prospective clinical studies. Currently in liver disease, dermatology, and gastroenterology, Pedestal Health\u2019s evidence generation capabilities deliver regulatory-grade insights, with a focus on translating complex data into decisions that improve patient care.<\/p>\n

\nHeadwater Science (formerly NoviSci) is a methodological and analytical engine for real-world data. With deep expertise in causal inference, comparative effectiveness, healthcare utilization and expenditure, and regulatory-grade software, Headwater Science brings principled, reproducible, and innovative data science to the most complex scientific questions in medicine. Alan Brookhart<\/a>, a leader in the development and application of methods for real-world evidence, recently returned to lead Headwater Science into this new phase.<\/p>\n

\nTogether, the two companies form the core of Highlander Health’s vision to reduce treatment access time by 50% through continuous evidence generation and more personalized care, modernizing episodic, start-from-scratch studies with an infrastructure that compounds over time. The companies were the inaugural investment of Highlander Health, a firm co-founded by industry veterans Amy Abernethy, M.D., Ph.D., and Brad Hirsch, M.D. to advance evidence generation and personalized healthcare for the new era of medical innovation.<\/p>\n

\n\u201cThe evidence system underpinning drug development has been operating on an outdated model: studies run in isolation, programs that reset with each question and insights that arrive too late to shape time-sensitive decisions. Pedestal Health and Headwater Science are built around a different premise: that evidence should be continuous, cumulative and designed from the start to inform care,\u201d said Amy Abernethy, co-CEO of Pedestal Health and Headwater Science.<\/p>\n

\nCo-CEO of Pedestal Health and Headwater Science, Brad Hirsch added: \u201cAmy and I founded Highlander Health to solve some of the biggest challenges facing healthcare. The rebrands represent more than a name change. They reflect a shared conviction: that the evidence system powering today\u2019s drug development was not built for what modern science demands.\u201d<\/p>\n

\nThe rebrands will be formally introduced at the ISPOR Annual Meeting<\/a>, May 17-20 in Philadelphia, where leaders from both companies will engage with industry stakeholders and share more about their combined vision and capabilities. You can also visit the team in person at booth 1111.<\/p>\n

\nAbout Pedestal Health<\/i><\/b><\/p>\n

\nPedestal Health (formerly Target RWE) combines deep health system partnerships, longitudinal data curation at scale, and modern study design to build continuous, high-quality evidence for life sciences organizations. The company partners with pharmaceutical and biotech companies, providers and payers to generate rigorous, multimodal evidence that supports clinical, regulatory and strategic decision-making across the full lifecycle of care. Pedestal Health is committed to advancing medical decision-making to improve outcomes for patients. Pedestal Health is a Highlander Health company. Learn more at pedestalhealth.com<\/a>.<\/i><\/p>\n

\nAbout Headwater Science<\/i><\/b><\/p>\n

\nHeadwater Science (formerly NoviSci) is a data science and methods company specializing in principled, reproducible evidence generation for complex clinical and regulatory challenges. With deep expertise in comparative effectiveness, causal inference, healthcare utilization and expenditure research, and regulatory-grade analytical software, Headwater Science provides the methodological foundation that delivers reproducible analytic pipelines, novel epidemiologic and statistical methods, and regulatory-grade software validated to hold up under the most demanding scrutiny. The company works with life sciences organizations as a long-term scientific partner. Headwater Science is a Highlander Health company. Learn more at <\/i>headwaterscience.com<\/i><\/a>.<\/i><\/p>\n

\nAbout Highlander Health<\/i><\/b><\/p>\n

\nHighlander Health is focused on advancing evidence generation for the new era of medical innovation. Through an investment portfolio and a platform for learning across care settings, Highlander Health is on a mission to modernize clinical research and care \u2014 toward flexible approaches, unlocked capacity, and faster and greater patient impact. Learn more and join in our work to move evidence generation forward at highlanderhealth.com<\/a>.<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact for Headwater Science and Pedestal Health:
\n
Nicole Contardo
\n
720-838-8416
\n
ncontardo@pedestalhealth.com<\/a><\/p>\n

Media Contact for Highlander Health:
\n
Rachel Ford Hutman
\n
Rachel@fordhutmanmedia.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New identities advance a modern approach to evidence generation DURHAM, N.C.–(BUSINESS WIRE)–Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63122","6":"format-standard","7":"category-industry"},"yoast_head":"\nTarget RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New identities advance a modern approach to evidence generation DURHAM, N.C.–(BUSINESS WIRE)–Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-18T11:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science\",\"datePublished\":\"2026-05-18T11:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/\"},\"wordCount\":730,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260518168034\\\/en\\\/2807293\\\/22\\\/PH_HS.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/\",\"name\":\"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260518168034\\\/en\\\/2807293\\\/22\\\/PH_HS.jpg\",\"datePublished\":\"2026-05-18T11:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260518168034\\\/en\\\/2807293\\\/22\\\/PH_HS.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260518168034\\\/en\\\/2807293\\\/22\\\/PH_HS.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/","og_locale":"en_US","og_type":"article","og_title":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend","og_description":"New identities advance a modern approach to evidence generation DURHAM, N.C.–(BUSINESS WIRE)–Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-18T11:03:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science","datePublished":"2026-05-18T11:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/"},"wordCount":730,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/","url":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/","name":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg","datePublished":"2026-05-18T11:03:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260518168034\/en\/2807293\/22\/PH_HS.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/target-rwe-and-novisci-rebrand-as-pedestal-health-and-headwater-science\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63122"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63122\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}